Clinical Trial Update: The Effect of Neoadjuvant DMPA on Glandular Cellularity in Women Awaiting Hysterectomy [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial investigates neoadjuvant Depot medroxyprogesterone acetate before hysterectomy to assess changes in glandular cellularity in women w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer
• Endometrial Endometrioid Adenocarcinoma
• Endometrial Hyperplasia with Atypia

Drugs mentioned

• Depot Medroxyprogesterone Acetate (medroxyprogesterone acetate)

Snippet

Sponsor: Women and Infants Hospital of Rhode Island | Conditions: Grade 1 Endometrial Endometrioid Adenocarcinoma, Grade 2 Endometrial Endometrioid Adenocarcinoma | Phase 2 | Status: UNKNOWN